MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-65 Cr |
Mar2024 | ₹-69 Cr |
Mar2023 | ₹198 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-65 Cr | Negative | |
Mar2024 | ₹-69 Cr | Negative | |
Mar2023 | ₹198 Cr | 148.81 | |
Mar2022 | ₹80 Cr | Positive | |
Mar2021 | ₹-15 Cr | - |
Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,702.3 Cr | 1.9% | -8.7% | 12.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.9% |
-8.7% |
12.8% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses